Evidence map›Paper›PMID 25183809›Full record

ArticleJournal of the American Society of Nephrology : JASN2015

Activation of hypoxia-inducible factors prevents diabetic nephropathy.

Lina Nordquist, Malou Friederich-Persson, Angelica Fasching, Per Liss, Kumi Shoji, Masaomi Nangaku, Peter Hansell, Fredrik Palm

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 1 synthesis or guideline pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Crosstalk between glomeruli and tubules.Nature reviews. Nephrology · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Lina NordquistDivision of Integrative Physiology, Department of Medical Cell Biology and.
Malou Friederich-PerssonDivision of Integrative Physiology, Department of Medical Cell Biology and.
Angelica FaschingDivision of Integrative Physiology, Department of Medical Cell Biology and.
Per LissDepartment of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden;
Kumi ShojiDivision of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan; and.
Masaomi NangakuDivision of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan; and.
Peter HansellDivision of Integrative Physiology, Department of Medical Cell Biology and.
Fredrik PalmDivision of Integrative Physiology, Department of Medical Cell Biology and Division of Drug Research, Department of Medical and Health Sciences and Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden Fredrik.Palm@mcb.uu.se.
The University of Tokyo · JPUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperglycemia results in increased oxygen consumption and decreased oxygen tension in the kidney. We tested the hypothesis that activation of hypoxia-inducible factors (HIFs) protects against diabetes-induced alterations in oxygen metabolism and kidney function. Experimental groups consisted of control and streptozotocin-induced diabetic rats treated with or without chronic cobalt chloride to activate HIFs. We elucidated the involvement of oxidative stress by studying the effects of acute administration of the superoxide dismutase mimetic tempol. Compared with controls, diabetic rats displayed tissue hypoxia throughout the kidney, glomerular hyperfiltration, increased oxygen consumption, increased total mitochondrial leak respiration, and decreased tubular sodium transport efficiency. Diabetic kidneys showed proteinuria and tubulointerstitial damage. Cobalt chloride activated HIFs, prevented the diabetes-induced alterations in oxygen metabolism, mitochondrial leak respiration, and kidney function, and reduced proteinuria and tubulointerstitial damage. The beneficial effects of tempol were less pronounced after activation of HIFs, indicating improved oxidative stress status. In conclusion, activation of HIFs prevents diabetes-induced alteration in kidney oxygen metabolism by normalizing glomerular filtration, which reduces tubular electrolyte load, preventing mitochondrial leak respiration and improving tubular transport efficiency. These improvements could be related to reduced oxidative stress and account for the reduced proteinuria and tubulointerstitial damage. Thus, pharmacologic activation of the HIF system may prevent development of diabetic nephropathy.

Indexed as

AnimalsAntioxidantsCobaltCyclic N-OxidesDiabetes Mellitus, ExperimentalDiabetic NephropathiesDisease Models, AnimalGlomerular Filtration RateHypoxia-Inducible Factor 1KidneyMaleOxidative StressOxygen ConsumptionRatsRats, Sprague-DawleySpin LabelsAntioxidantsCobaltcobaltous chlorideCyclic N-OxidesHypoxia-Inducible Factor 1Spin Labelstempoldiabetic nephropathyhypoxiaproteinuria

Identifiers

PMID25183809
PMCPMC4310648
OpenAlexW2101901896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.